SN

Sivakumar Natarajan

Active Director Director DIN 05270782
DIN 05270782 First appointment May 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2012
Shareholding value •••• Premium profile

About Sivakumar Natarajan

Data last updated:

Sivakumar Natarajan is a Director at Praval Pharmaceuticals Private Limited (since 2012). The company operates in Chemicals. Praval Pharmaceuticals Private Limited reported revenue of ₹14.6 Lakh (FY 2025).

DIN 05270782
Primary Designation Director
Industry Chemicals
First Appointment 04 May 2012
Oldest Company Age 16 yrs
Largest company Praval Pharmaceuticals Private Limited · ₹14.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 May 20122010₹14.6 Lakh (FY 2025)Active

Board colleagues of Sivakumar Natarajan

Directorship timeline

Open interactive timeline →
Praval Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sivakumar Natarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivakumar Natarajan

Sivakumar Natarajan currently holds 1 directorship: Praval Pharmaceuticals Private Limited (Director, since 04 May 2012, revenue ₹14.6 Lakh (FY 2025)).

Sivakumar Natarajan was first appointed on 04 May 2012 as Director at Praval Pharmaceuticals Private Limited.

The current boards of Sivakumar Natarajan's companies include Krishnamurthy Ravisankar (Praval Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available